Blueprint Medicines Corp. Company Profile (NASDAQ:BPMC)

About Blueprint Medicines Corp.

Blueprint Medicines Corp. logoBlueprint Medicines Corporation is a biopharmaceutical company. The Company focuses on patients with genomically defined diseases driven by abnormal kinase activation. The Company focuses on crafting drug candidates with therapeutic windows that provide clinical responses to patients without adequate treatment options. The Company has developed a small molecule drug pipeline in cancer and a genetic disease. The Company's drug candidate, BLU-285, targets KIT Exon 17 mutants and PDGFRa D842V, which are abnormally active receptor tyrosine kinase mutants that are drivers of cancer and proliferative disorders. It is engaged in developing BLU-285 for patients with systemic mastocytosis (SM), a myeloproliferative disorder of the mast cells, and defined subsets of patients with gastrointestinal stromal tumor (GIST). Its drug candidate, BLU-554, targets FGFR4, a kinase that is aberrantly activated and is a driver of disease in a defined subset of patients with hepatocellular carcinoma (HCC).

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: BPMC
  • CUSIP:
Key Metrics:
  • Previous Close: $28.04
  • 50 Day Moving Average: $23.42
  • 200 Day Moving Average: $19.41
  • 52-Week Range: $13.04 - $31.94
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -7.03
  • P/E Growth: 0.00
  • Market Cap: $773.79M
  • Outstanding Shares: 27,227,000
  • Beta: 1.64
Additional Links:
Companies Related to Blueprint Medicines Corp.:

Analyst Ratings

Consensus Ratings for Blueprint Medicines Corp. (NASDAQ:BPMC) (?)
Ratings Breakdown: 6 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $29.83 (5.27% upside)

Analysts' Ratings History for Blueprint Medicines Corp. (NASDAQ:BPMC)
Show:
DateFirmActionRatingPrice TargetDetails
8/9/2016Cowen and CompanyReiterated RatingBuyView Rating Details
8/9/2016WedbushReiterated RatingOutperform$41.00View Rating Details
8/5/2016Canaccord GenuityInitiated Coverage` -> Buy$26.00View Rating Details
5/27/2016Raymond James Financial Inc.Initiated CoverageOutperform$23.00View Rating Details
3/9/2016JPMorgan Chase & Co.Lower Price TargetMarket Outperform$54.00 -> $37.00View Rating Details
3/9/2016JMP SecuritiesLower Price TargetMarket Outperform$54.00 -> $37.00View Rating Details
2/22/2016Goldman Sachs Group Inc.Lower Price Target$26.00 -> $15.00View Rating Details
(Data available from 8/30/2014 forward)

Earnings

Earnings History for Blueprint Medicines Corp. (NASDAQ:BPMC)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/7/2016        
8/9/2016Q216($0.73)($0.70)$4.41 million$7.07 millionViewListenView Earnings Details
5/10/2016Q116($0.70)($0.57)$3.24 million$6.90 millionViewListenView Earnings Details
3/11/2016Q415($0.53)($0.58)$2.85 million$4.64 millionViewN/AView Earnings Details
11/9/2015Q3($0.54)($0.47)$1.83 million$3.43 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Blueprint Medicines Corp. (NASDAQ:BPMC)
Current Year EPS Consensus Estimate: $-3.05 EPS
Next Year EPS Consensus Estimate: $-4.03 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q2 20161($0.82)($0.82)($0.82)
Q3 20161($0.77)($0.77)($0.77)
Q4 20161($0.84)($0.84)($0.84)
Q1 20171($0.93)($0.93)($0.93)
Q2 20171($0.99)($0.99)($0.99)
Q3 20171($1.19)($1.19)($1.19)
Q4 20171($1.43)($1.43)($1.43)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Blueprint Medicines Corp. (NASDAQ:BPMC)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Blueprint Medicines Corp. (NASDAQ:BPMC)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/8/2016Jeffrey W AlbersCEOSell17,000$22.86$388,620.00View SEC Filing  
6/3/2016Jeffrey W AlbersCEOSell17,000$20.03$340,510.00View SEC Filing  
4/13/2016Christoph LengauerInsiderSell15,872$20.01$317,598.72View SEC Filing  
4/12/2016Christoph LengauerInsiderSell18,853$20.14$379,699.42View SEC Filing  
4/6/2016Jeffrey W AlbersCEOSell17,000$20.42$347,140.00View SEC Filing  
12/17/2015Christoph LengauerinsiderSell31,119$25.05$779,530.95View SEC Filing  
11/27/2015Fmr LlcInsiderSell287,415$21.48$6,173,674.20View SEC Filing  
11/24/2015Fmr LlcInsiderSell161,271$20.14$3,247,997.94View SEC Filing  
11/23/2015Fmr LlcInsiderSell189,572$20.15$3,819,875.80View SEC Filing  
11/19/2015Fmr LlcInsiderSell237,218$19.76$4,687,427.68View SEC Filing  
11/17/2015Fmr LlcInsiderSell27,490$20.60$566,294.00View SEC Filing  
11/3/2015Christoph LengauerinsiderSell84,998$21.05$1,789,207.90View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Blueprint Medicines Corp. (NASDAQ:BPMC)
DateHeadline
finance.yahoo.com logoBLUEPRINT MEDICINES CORP Financials (NASDAQ:BPMC)
finance.yahoo.com - August 24 at 3:55 PM
finance.yahoo.com logoBLUEPRINT MEDICINES CORP Financials (NASDAQ:BPMC)
finance.yahoo.com - August 24 at 3:55 PM
biz.yahoo.com logoBLUEPRINT MEDICINES CORP Files SEC form 8-K, Entry into a Material Definitive Agreement (NASDAQ:BPMC)
biz.yahoo.com - August 23 at 9:10 PM
capitalcube.com logoETF’s with exposure to Blueprint Medicines Corp. : August 23, 2016 (NASDAQ:BPMC)
www.capitalcube.com - August 23 at 4:02 PM
finance.yahoo.com logoWhy Blueprint Medicines (BPMC) Stock Might be a Great Pick (NASDAQ:BPMC)
finance.yahoo.com - August 16 at 11:55 AM
capitalcube.com logoBlueprint Medicines Corp. :BPMC-US: Earnings Analysis: Q2, 2016 By the Numbers : August 10, 2016 (NASDAQ:BPMC)
www.capitalcube.com - August 10 at 3:23 PM
finance.yahoo.com logoEdited Transcript of BPMC earnings conference call or presentation 9-Aug-16 12:30pm GMT (NASDAQ:BPMC)
finance.yahoo.com - August 10 at 3:23 PM
cnbc.com logoBlueprint Medicines reports 2Q loss (NASDAQ:BPMC)
www.cnbc.com - August 9 at 5:04 PM
publicnow.com logoBlueprint Medicines to Present at Upcoming Investor Conferences in August (NASDAQ:BPMC)
www.publicnow.com - August 3 at 12:34 PM
publicnow.com logoBlueprint Medicines to Report Second Quarter 2016 Financial Results on Tuesday, August 9, 2016 (NASDAQ:BPMC)
www.publicnow.com - August 2 at 8:44 AM
capitalcube.com logoBlueprint Medicines Corp. breached its 50 day moving average in a Bearish Manner : BPMC-US : June 28, 2016 (NASDAQ:BPMC)
www.capitalcube.com - June 28 at 8:18 AM
biz.yahoo.com logoBLUEPRINT MEDICINES CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders (NASDAQ:BPMC)
biz.yahoo.com - June 24 at 4:31 PM
capitalcube.com logoETF’s with exposure to Blueprint Medicines Corp. : June 20, 2016 (NASDAQ:BPMC)
www.capitalcube.com - June 20 at 2:07 PM
fidaily.com logoBlueprint Medicines Corporation (NASDAQ:BPMC) Trading Up – Insider Trading Activity (NASDAQ:BPMC)
www.fidaily.com - June 7 at 9:32 PM
capitalcube.com logoETF’s with exposure to Blueprint Medicines Corp. : June 7, 2016 (NASDAQ:BPMC)
www.capitalcube.com - June 7 at 5:29 PM
capitalcube.com logoBlueprint Medicines Corp. :BPMC-US: Earnings Analysis: Q1, 2016 By the Numbers : June 2, 2016 (NASDAQ:BPMC)
www.capitalcube.com - June 2 at 9:59 AM
publicnow.com logoBlueprint Medicines to Present at Upcoming Investor Conferences in June (NASDAQ:BPMC)
www.publicnow.com - June 1 at 4:25 PM
finance.yahoo.com logoCoverage initiated on Blueprint Medicines by Raymond James (NASDAQ:BPMC)
finance.yahoo.com - May 27 at 8:20 AM
News IconEarnings Review and Stock Rundown for Blueprint Medicines Corp (NASDAQ:BPMC) - Wall Street Hints and News (NASDAQ:BPMC)
hintsnewsnetwork.com - May 26 at 8:45 AM
realistinvestor.com logoBlueprint Medicines Corp (NASDAQ:BPMC) Closes At $18.23 - RealistInvestor.com (NASDAQ:BPMC)
www.realistinvestor.com - May 26 at 8:45 AM
capitalcube.com logoBlueprint Medicines Corp. – Value Analysis (NASDAQ:BPMC) : May 23, 2016 (NASDAQ:BPMC)
www.capitalcube.com - May 23 at 5:49 PM
capitalcube.com logoBlueprint Medicines Corp. breached its 50 day moving average in a Bullish Manner : BPMC-US : May 20, 2016 (NASDAQ:BPMC)
www.capitalcube.com - May 20 at 8:06 AM
finance.yahoo.com logoEdited Transcript of BPMC earnings conference call or presentation 10-May-16 12:00pm GMT (NASDAQ:BPMC)
finance.yahoo.com - May 11 at 2:44 PM
biz.yahoo.com logoBlueprint Medicines Corp Earnings Call scheduled for 8:00 am ET today (NASDAQ:BPMC)
biz.yahoo.com - May 10 at 8:00 AM
sg.finance.yahoo.com logoBlueprint Medicines reports 1Q loss (NASDAQ:BPMC)
sg.finance.yahoo.com - May 10 at 7:26 AM
publicnow.com logoBlueprint Medicines Reports First Quarter 2016 Financial Results (NASDAQ:BPMC)
www.publicnow.com - May 10 at 7:18 AM
biz.yahoo.com logoBLUEPRINT MEDICINES CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and (NASDAQ:BPMC)
biz.yahoo.com - May 10 at 7:17 AM
biz.yahoo.com logoQ1 2016 Blueprint Medicines Corp Earnings Release - Time Not Supplied (NASDAQ:BPMC)
biz.yahoo.com - May 10 at 7:07 AM
News IconBlueprint Medicines Corporation (NASDAQ:BPMC) Broker Price Targets For The Coming Week - Share Trading News (NASDAQ:BPMC)
www.sharetrading.news - May 8 at 2:56 PM
insidermonkey.com logoBlueprint Medicines Corp (BPMC): Biotechnology Value Fund Reports 10.4% Stake - Insider Monkey (blog) (NASDAQ:BPMC)
www.insidermonkey.com - May 7 at 3:02 PM
News IconBlueprint Medicines Corp (BPMC): Biotechnology Value Fund Reports 10.4% Stake (NASDAQ:BPMC)
feedproxy.google.com - May 5 at 3:40 PM
publicnow.com logoBlueprint Medicines to Report First Quarter 2016 Financial Results on Tuesday, May 10, 2016 (NASDAQ:BPMC)
www.publicnow.com - May 3 at 8:30 AM
capitalcube.com logoETF’s with exposure to Blueprint Medicines Corp. : April 28, 2016 (NASDAQ:BPMC)
www.capitalcube.com - April 28 at 1:03 PM
capitalcube.com logoBlueprint Medicines Corp. breached its 50 day moving average in a Bearish Manner : BPMC-US : April 27, 2016 (NASDAQ:BPMC)
www.capitalcube.com - April 27 at 8:36 AM
News IconBlueprint Medicines Corp (NASDAQ:BPMC) Share Rating Recap - The Post (NASDAQ:BPMC)
www.bibeypost.com - April 24 at 2:46 PM
bizjournals.com logoA year after the state's biggest biotech IPO, Blueprint Medicines maps out a plan (NASDAQ:BPMC)
www.bizjournals.com - April 22 at 8:43 PM
smarteranalyst.com logoStock Update (NASDAQ:BPMC): Blueprint Medicines Corp Appoints Lynn Seely, MD to Board of Directors - Smarter Analyst (NASDAQ:BPMC)
www.smarteranalyst.com - April 17 at 2:51 PM
clintongazette.com logoBlueprint Medicines Corp (NASDAQ:BPMC) Analyst Recommendation Outlook - Clinton Financial (NASDAQ:BPMC)
www.clintongazette.com - April 16 at 2:54 PM
biz.yahoo.com logoBLUEPRINT MEDICINES CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhi (NASDAQ:BPMC)
biz.yahoo.com - April 15 at 4:31 PM
publicnow.com logoBlueprint Medicines Appoints Lynn Seely, M.D. to Board of Directors (NASDAQ:BPMC)
www.publicnow.com - April 15 at 8:19 AM
clintongazette.com logoIs Blueprint Medicines Corp (NASDAQ:BPMC) a Consensus Buy? - Clinton Financial (NASDAQ:BPMC)
www.clintongazette.com - April 9 at 2:55 PM
News IconNew Analyst Ratings On Blueprint Medicines Corporation (NASDAQ:BPMC) - Risers & Fallers (NASDAQ:BPMC)
www.risersandfallers.com - April 9 at 2:55 PM
finance.yahoo.com logoWill Blueprint Medicines (BPMC) Continue to Surge Higher? (NASDAQ:BPMC)
finance.yahoo.com - April 8 at 8:26 AM
News IconPartner Fund Management Has Confidence In Blueprint Medicines Corp (BPMC) (NASDAQ:BPMC)
feedproxy.google.com - April 7 at 11:37 PM
News IconAnalyst Ratings Check Blueprint Medicines Corp (NASDAQ:BPMC) - Business Standard Tribune (NASDAQ:BPMC)
www.standardtrib.com - April 5 at 2:56 PM
News IconBlueprint Medicines Corporation (NASDAQ:BPMC) Latest Broker Coverage - Risers & Fallers (NASDAQ:BPMC)
www.risersandfallers.com - April 5 at 2:56 PM
stocksdaily.net logoCan Shares Of Blueprint Medicines Corp (NASDAQ:BPMC) Touch $41? - Stocks Daily (NASDAQ:BPMC)
www.stocksdaily.net - April 5 at 2:56 PM
publicnow.com logoBlueprint Medicines to Present at 15th Annual Needham Healthcare Conference (NASDAQ:BPMC)
www.publicnow.com - April 5 at 8:20 AM
News IconCompany Shares of Blueprint Medicines Corporation (NASDAQ:BPMC) Rally 11.31% - Street Edition (NASDAQ:BPMC)
www.streetedition.net - April 4 at 2:49 PM
News IconGoldman Sachs rated Blueprint Medicines Corp (NASDAQ:BPMC) to Target Down, Sets Target Price to $15 - The Duncan Independent (press release) (blog) (NASDAQ:BPMC)
www.duncanindependent.com - April 3 at 2:42 PM

Social

Blueprint Medicines Corp. (NASDAQ:BPMC) Chart for Tuesday, August, 30, 2016


Last Updated on 8/30/2016 by MarketBeat.com Staff